Loading chat...
IN SB0631
Bill
AI Summary
-
Adds "fentanyl related substance" as a new defined term covering substances structurally related to fentanyl through specific chemical modifications, and places these substances in Schedule I effective July 1, 2019
-
Moves acetyl fentanyl from the synthetic drugs definition to the Schedule I opiates list, along with adding numerous other fentanyl analogs including 4-fluoroisobutyryl fentanyl, furanyl fentanyl, and cyclopentyl fentanyl
-
Adds Thiafentanil to Schedule II controlled substances and adds 4-Anilino-N-Phenethyl-4-Piperidine (ANPP) as an immediate precursor to fentanyl
-
Adds Epidiolex and Brivaracetam to Schedule V controlled substances, and specifies that dronabinol is Schedule II only in oral solution form
-
Expands the synthetic drug definition to include additional chemical compounds and structural classes including MT-45, various synthetic cannabinoids (5F-ADB, 5F-AMB, ADB-FUBINACA), and synthetic cathinones (N-ethylpentylone/ephylone)
Legislative Description
Drug classifications and drug schedules. Adds numerous substances to the definition of "synthetic drug". Adds epidiolex and brivaracetam to schedule V. Specifies that dronabinol is a schedule II controlled substance only in oral solution. Defines "fentanyl related substance" and adds it to schedule I. Moves certain fentanyl related substances from the definition of "synthetic drugs" in schedule II to schedule I. Adds Thiafentanil to schedule II. Makes conforming changes.
Last Action
Public Law 119
4/29/2019